SynthesisBMC women's health2025

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis.

Shiya Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.